Patents by Inventor David Peter Hoile

David Peter Hoile has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline polymorphic form of glucokinase activator
    Patent number: 8093252
    Abstract: A new polymorphic form of 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzamide, processes for making it and its use as an activator of glucokinase are described.
    Type: Grant
    Filed: February 15, 2010
    Date of Patent: January 10, 2012
    Assignee: AstraZeneca AB
    Inventors: Sharon Ann Bowden, David Peter Hoile, Karin Lövqvist
  • CRYSTALLINE POLYMORPHIC FORM 631
    Publication number: 20100210621
    Abstract: A new polymorphic form of 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzamide, processes for making it and its use as an activator of glucokinase are described.
    Type: Application
    Filed: February 15, 2010
    Publication date: August 19, 2010
    Applicant: AstraZeneca AB
    Inventors: Sharon Ann BOWDEN, David Peter HOILE, Karin LÖVQVIST